AIM ImmunoTech Inc.

09/27/2021 | Press release | Distributed by Public on 09/27/2021 07:22

AIM ImmunoTech Files Provisional Patent Application for Ampligen as an Early-Onset Intranasal Therapy that May Also Confer Enhanced Immunity to a Wide Range of Respiratory Viruses